• Investor

Meryeme Lahmami

Principal Pender Ventures

Based in Montreal, Meryeme joined Pender in 2022 bringing 8+ years experience in healthcare and enterprise software both as an operator and investor.

Before joining Pender, Meryeme most recently worked at BDC Capital’s Women In Tech Venture Fund, where she led investments for multiple early-stage / growth companies across Biotech, enterprise software and digital health. Prior to BDC Capital, Meryeme was at Medteq where she solely focused on early-stage investments in digital health, diagnostics and medical device companies.

Meryeme started her career as a consultant in bioproducts and wearables before co-founding a venture-backed health tech startup. Meryeme is active in the startup community, including mentorship roles with a number of Montreal-based incubators and accelerators. She holds an MBA from Laval University.

Super Early Bird Pricing
Join The Founders Shaping The Future Of AI-SaaS
Super Early Bird passes available for a limited time.
SAVE $600
Regular Price: $1,199 /person
* When you buy 3 or more tickets

Keep Exploring

We have a lot more exciting things for you to check out about this event!

2025 Agenda

Last Year’s Theme: Future-Proofing SaaS in the Age of AI

From go-to-market to product innovation, this year’s agenda is packed with real strategies, tools, and frameworks to help you adapt, scale, and thrive with AI.

Apply To Exhibit

You bring the booth. We bring the buyers.

Let’s turn badge scans into booked meetings—and pipeline magic.

Apply To Speak

Got something real to say? Good.

No recycled decks. Just operators sharing what’s actually working.

Stay In The Loop

Get speaker announcements, agenda updates, and early ticket access delivered straight to your inbox.

No spam. Just the good stuff.